Andreas Behren
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
Papers in
-
- Cancer Genomics and Diagnostics 17
- Protease and Inhibitor Mechanisms 2
- Oncology 25
- Cancer Immunotherapy and Biomarkers 19
- Cancer Cells and Metastasis 5
- Co-authors
- Jonathan Simon Cebon (44 shared papers)Matt Trau (8 shared papers)Yuling Wang (5 shared papers)Oliver Klein (10 shared papers)Alexander Dobrovic (8 shared papers)Alain Wuethrich (6 shared papers)Jing Wang (5 shared papers)Christopher Hudson (5 shared papers)
- Journals
- Nature Communications (13 papers)Nature (8 papers)Nature Genetics (5 papers)Oncotarget (5 papers)Scientific Reports (4 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Andreas Behren
103 papers receiving 14.6k citations
Andreas Behren's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 2.4k
- Oncology 2.0k
- Molecular Biology 2.5k
- Immunology 561
- Genetics 202
Countries citing papers authored by Andreas Behren
This map shows the geographic impact of Andreas Behren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Behren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Behren more than expected).
Fields of papers citing papers by Andreas Behren
This network shows the impact of papers produced by Andreas Behren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Behren. The network helps show where Andreas Behren may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Behren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2401 |
| 2 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2169 |
| 3 | Whole-genome landscapes of major melanoma subtypes Hit paper breakdown → | 2017 | 1109 |
| 4 | CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity Hit paper breakdown → | 2017 | 757 |
| 5 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 730 |
| 6 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 564 |
| 7 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 489 |
| 8 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 428 |
| 9 | 2020 | 344 | |
| 10 | Comprehensive molecular characterization of mitochondrial genomes in human cancers Hit paper breakdown → | 2020 | 319 |
| 11 | Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition Hit paper breakdown → | 2020 | 315 |
| 12 | Genomic basis for RNA alterations in cancer Hit paper breakdown → | 2020 | 310 |
| 13 | The landscape of viral associations in human cancers Hit paper breakdown → | 2020 | 293 |
| 14 | 2019 | 227 | |
| 15 | 2020 | 190 | |
| 16 | Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers Hit paper breakdown → | 2020 | 184 |
| 17 | 2020 | 167 | |
| 18 | 2020 | 161 | |
| 19 | 2015 | 156 | |
| 20 | 2021 | 156 |
About Andreas Behren
Andreas Behren is a scholar working on Cancer Research, Oncology, Immunology, Molecular Biology and Electronic, Optical and Magnetic Materials, having authored 106 papers that have together received 14.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), Cancer Genomics and Diagnostics (17 papers), T-cell and B-cell Immunology (6 papers), Melanoma and MAPK Pathways (6 papers), Cancer Cells and Metastasis (5 papers), Immunotherapy and Immune Responses (3 papers), Protease and Inhibitor Mechanisms (2 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Cancer Research (2.4k citations), Oncology (2.0k citations), Molecular Biology (2.5k citations), Immunology (561 citations) and Genetics (202 citations). Andreas Behren has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Jonathan Simon Cebon, Matt Trau, Yuling Wang, Oliver Klein, Alexander Dobrovic, Alain Wuethrich, Jing Wang, Christopher Hudson, Matthew Anaka and Abu Ali Ibn Sina. Their work appears in journals such as Nature Communications, Nature, Nature Genetics, Oncotarget and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.